Reimagining Point of Care Diagnostics

Atomo Diagnostics is transforming blood-based rapid diagnostic testing (RDT) with all-in-one test devices designed to simplify procedures, mitigate common user errors and enhance test performance.  Suitable for professional use and self-test applications, Atomo’s integrated RDT platforms offer unrivaled usability, safety and convenience.

Partner with Atomo Diagnostics for best-in-class lateral flow testing.

awards-2

Integrated RDT platforms

Award-winning AtomoRapid™ RDT platforms remove the need for multiple test components by integrating features into a single device. With assorted functionality, Atomo platforms greatly simplify test procedures.

Browse our portfolio >

Self-testing made simpler

With a built-in safety lancet, unique blood collection feature, single action blood and buffer delivery system, and interlocked user steps, Atomo’s Elion self-test platform provides unprecedented usability and performance.

Evaluate self-test features >

Custom device development

Discover how partnering with Atomo Diagnostics can provide an efficient and low-risk pathway from product development to commercialisation of your best-in-class rapid diagnostic test.

Partner with Atomo >

thumbsup

Unmatched Usability

All-in-one, user-centred device design tailored for professional use and self-test applications.

Committed to Quality

 Award-winning devices manufactured to the highest international standards, including ISO 9001 and ISO 13485.

Efficient Development

Validated processes to accelerate device development from product design through to commercial launch.

 Latest Updates

 Press Release

2911, 2018

PRESS RELEASE: Australian TGA approves Atomo HIV Self Test as first rapid diagnostic test for home use

SYDNEY, Australia,29 November 2018: Award-winning medical device developer Atomo Diagnostics today announced that its Atomo HIV Self Test has been approved for sale in Australia by the Therapeutic [...]

 News

Atomo HIV Self Test approved by TGA

November 29th, 2018|0 Comments

Today, Atomo Diagnostics announced that its Atomo HIV Self Test has been approved for sale in Australia by the Therapeutic Goods Administration (TGA).  It is the first and only diagnostic self-test for HIV to have received approval from Australia’s national regulator. Addressing [...]

 Blog

OEM Feature: NG Biotech Case Study

From its impressive and newly expanded manufacturing plant close to the beautiful village of Guipry in northwest France, NG Biotech is rapidly scaling-up production to meet growing demand for its innovative products. The village setting [...]